Nanhao Meng

Tianjin Key Laboratory Of Bone Marrow Failure And Malignant Hemopoietic Clone Control, State Key Laboratory Of Experimental Hematology
Tianjin, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Microvesicles derived from bone marrow and peripheral blood can reflect tumor load in multiple myeloma.

Microvesicles derived from bone marrow and peripheral blood can reflect tumor load in multiple myeloma.

Journal: Journal of translational internal medicine
Published: February 23, 2026

Osteoblasts inhibit NK cell killing function via RANK/RANKL in multiple myeloma.

Osteoblasts inhibit NK cell killing function via RANK/RANKL in multiple myeloma.

Journal: Journal of investigative medicine : the official publication of the American Federation for Clinical Research
Published: May 30, 2025

Kaempferol induces mitophagy and disrupts iron metabolism via SFXN2 leading to apoptosis in multiple myeloma cells.

Kaempferol induces mitophagy and disrupts iron metabolism via SFXN2 leading to apoptosis in multiple myeloma cells.

Journal: Free radical biology & medicine
Published: April 28, 2025

T-lymphocytes suppression by CD14+ monocytes with high expression of ULK2 in patients with multiple myeloma.

T-lymphocytes suppression by CD14+ monocytes with high expression of ULK2 in patients with multiple myeloma.

Journal: Journal of translational medicine
Published: March 18, 2025

BSA-AIE Nanoparticles with Boosted ROS Generation for Immunogenic Cell Death Immunotherapy of Multiple Myeloma.

BSA-AIE Nanoparticles with Boosted ROS Generation for Immunogenic Cell Death Immunotherapy of Multiple Myeloma.

Journal: Advanced materials (Deerfield Beach, Fla.)
Published: September 21, 2022

lncRNA MSTRG.29039.1 Promotes Proliferation by Sponging hsa-miR-12119 via JAK2/STAT3 Pathway in Multiple Myeloma.

lncRNA MSTRG.29039.1 Promotes Proliferation by Sponging hsa-miR-12119 via JAK2/STAT3 Pathway in Multiple Myeloma.

Journal: Oxidative medicine and cellular longevity
Published: April 03, 2021

Malignant plasmacytes in bone marrow detected by flow cytometry as a predictor for the risk stratification system of multiple myeloma.

Malignant plasmacytes in bone marrow detected by flow cytometry as a predictor for the risk stratification system of multiple myeloma.

Journal: Cytometry. Part B, Clinical cytometry
Published: December 09, 2020

Study on Tim3 Regulation of Multiple Myeloma Cell Proliferation via NF-κB Signal Pathways.

Study on Tim3 Regulation of Multiple Myeloma Cell Proliferation via NF-κB Signal Pathways.

Journal: Frontiers in oncology
Published: July 17, 2020

Bone marrow-derived mesenchymal stem cells inhibit CD8+ T cell immune responses via PD-1/PD-L1 pathway in multiple myeloma.

Bone marrow-derived mesenchymal stem cells inhibit CD8+ T cell immune responses via PD-1/PD-L1 pathway in multiple myeloma.

Journal: Clinical and experimental immunology
Published: May 30, 2020
Showing 1-9 of 9

Last Updated: 09/26/2026